FAM3A Deficiency - Induced Mitochondrial Dysfunction Underlies Post-Infarct Mortality and Heart Failure
- PMID: 37014466
- DOI: 10.1007/s12265-023-10382-w
FAM3A Deficiency - Induced Mitochondrial Dysfunction Underlies Post-Infarct Mortality and Heart Failure
Abstract
Mitochondrial protein sequence similarity 3 gene family member A (FAM3A) plays important roles in the electron transfer chain, while its functions in the heart are still unknown. This study aims to explore the roles and mechanisms of FAM3A after myocardial infarction (MI). FAM3A-deficient (Fam3a-/-) mice were implemented with MI injury and showed lower survival rates at 4 weeks as well as decreased cardiac systolic function. Isolated cardiomyocytes of Fam3a-/- mice showed reduced basal, ATP-linked respiration and respiratory reserve compared to that of wild-type mice. Transmission electron microscopy studies showed Fam3a-/- mice had a larger size and elevated density of mitochondria. FAM3A deficiency also induced elevated mitochondrial Ca2+, higher opening level of mPTP, lower mitochondrial membrane potential and elevated apoptotic rates. Further analyses demonstrated that mitochondrial dynamics protein Opa1 contributed to the effects of FAM3A in cardiomyocytes. Our study discloses the important roles of mitochondrial protein FAM3A in the heart.
Keywords: FAM3A; Heart failure; Mitochondrial dysfunction; Myocardial infarction; Opa1.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Comment in
-
FAM3A As a Potential Molecular Target to Regulate Mitochondrial Respiration and ATP Production in Ischemic Heart.J Cardiovasc Transl Res. 2024 Feb;17(1):102-103. doi: 10.1007/s12265-023-10435-0. Epub 2023 Sep 5. J Cardiovasc Transl Res. 2024. PMID: 37668896 No abstract available.
References
-
- Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B. ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol. 2021;2021. https://doi.org/10.1093/eurjpc/zwab154
-
- Yue R, Xia X, Jiang J, Yang D, Han Y, Chen X, Cai Y, Li L, Wang WE, Zeng C. Mitochondrial DNA oxidative damage contributes to cardiomyocyte ischemia/reperfusion-injury in rats: cardioprotective role of lycopene. J Cell Physiol. 2015;230(9):2128–41. https://doi.org/10.1002/jcp.24941 . - DOI - PubMed
-
- Sun N, Finkel T. Cardiac mitochondria: a surprise about size. J Mol Cell Cardiol. 2015;82:213–5. https://doi.org/10.1016/j.yjmcc.2015.01.009 . - DOI - PubMed - PMC
-
- Virmani R, Forman MB, Kolodgie FD. Myocardial reperfusion injury. Histopathological effects of perfluorochemical. Circulation. 1990;81(3 Suppl):Iv57-68
-
- Giorgi C, Marchi S, Pinton P. The machineries, regulation and cellular functions of mitochondrial calcium. Nat Rev Mol Cell Biol. 2018;19(11):713–30. https://doi.org/10.1038/s41580-018-0052-8 . - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 2021RU003/Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences and Peking Union Medical College
- 81900315/National Natural Science Foundation of China
- U20A20345/National Natural Science Foundation of China
- 82270343/National Natural Science Foundation of China
- 2020YFA0803800/Key Technologies Research and Development Program
LinkOut - more resources
Full Text Sources